Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01163 encodes a long non-coding RNA (lncRNA) located on chromosome 10q26.2 (genomic coordinates: 10:128181032-128317726, GRCh38 assembly)[1][3][5][8]. It is characterized as a non-protein coding transcript, sharing structural features typical of lncRNAs. Its alternative names include TCONS_00017722. The biological roles, clinical relevance, and specific molecular interactions of LINC01163 remain largely uncharacterized; it has not been classified as a conventional therapeutic target such as a receptor, enzyme, or transporter. As a lncRNA, it may be involved in the regulation of gene expression and chromatin structure, as seen with other members of this RNA class[1][9][10]. No direct links to specific diseases, drugs, or established biomarker use have been reported for this gene. At present, LINC01163 should not be considered a classical drug target but may gain interest as basic lncRNA research progresses.
Not applicable; no approved or known drugs directly targeting LINC01163
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1163 (LINC01163).